Hydrocephalus: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• AQP4 0
• AMPK 0
• mTOR 1
• SNCA 0
• VEGF 0
• ALK 0
• ATM 0
• B7-H3 0
• C9orf72 0
• CD47 0
• CDKN2A 0
• CFTR 1
• CSF1R 0
• DMD 1
• ERK 0
• FGFR 0
• GLP-1 0
• HTT 1
• MEK 0
• MMP-9 0
• NF1 1
• NMDA 0
• PIK3CA 0
• RET 0
• SGLT2 0
• SMN1 1
• STAT3 0
• STING 0
• TDP-43 1
• TIM-3 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NINDS · R61

  Active surveillance and differential diagnosis of shunt complications in hydrocephalus patients using wearable ultrasound

  Johns Hopkins University· Baltimore, United States· US$532,224 awarded in fiscal year 2026· until Aug 2028

• NIH NICHD · R56

  The functional screening of congenital hydrocephalus and heart disease genes in Xenopus

  Yale University· New Haven, United States· US$499,656 awarded in fiscal year 2026· until Aug 2027

• NIH NICHD · R21

  A Forward Genetic Screen to Identify Genes Involved in Left-Right Patterning

  Princeton University· Princeton, United States· US$451,000 awarded in fiscal year 2026· until Aug 2028

• NIH NICHD · R01

  THiamine for Recovery In Vulnerable Early-life infections (THRIVE)

  Pennsylvania State Univ Hershey Med Ctr· Hershey, United States· US$662,474 awarded in fiscal year 2026· until Jul 2031

• NIH NIGMS · R35

  Structure, Function, and Regulation of Ciliary Complexes in Motility, Evolution, and Disease

  Ut Southwestern Medical Center· Dallas, United States· US$556,694 awarded in fiscal year 2026· until Mar 2031

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Waveform-based prediction of AD-related pathology for patient diagnostics (WAVEAD)

  Ita-Suomen Yliopisto· Kuopio, Finland· EU contribution €150,000· until Jun 2027

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Development of human 3D organoid model of Alzheimer's disease (MIND-AD)

  Ita-Suomen Yliopisto· Kuopio, Finland· EU contribution €242,117· until Dec 2027

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Window to the brain: a game changer in the discovery of human neuronal circuitry, cellular heterogenicity and biomarker profile indicative of early Alzheimer's disease -related pathology (HUMANE)

  Ita-Suomen Yliopisto· Kuopio, Finland· EU contribution €1,998,389· until Aug 2027

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon 2020) · ERC-ADG

  Portable, accessible and sustainable magnetic resonance (PASMAR)

  Academisch Ziekenhuis Leiden· Leiden, Netherlands· EU contribution €2,493,715· until Aug 2027

  The disease is named only in the funder's project summary, not in the title.

9 of 82 running projects, newest first. Listed amounts together: US$40.3m + €4.9m.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Trials whose registry record says individual participant data (IPD) will be shared.

No trial in this view states that it shares participant data.

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Mendelian Randomization Analysis 2
• Exome Sequencing 9
• Proteomics 6
• Metabolomics 2
• Immunohistochemistry 2
• Positron-Emission Tomography 5
• Magnetic Resonance Imaging 174
• Machine Learning 12
• Deep Learning 14
• Cohort Studies 53
• Genome-Wide Association Study 3

• Phosphoproteomic Insights into TRPV4-AMPK Signaling Axis and Barrier Regulation in the Choroid Plexus Epithelium.

  Int J Mol Sci, Sept 2026

• Live brain biopsy during CSF shunt surgery for precision diagnostics and multi-omic research.

  Alzheimers Res Ther, Aug 2026

• Proteomic composition and mutual assembly of the C2a projection in vertebrate motile cilia.

  Elife, Jul 2026

• Decoding the CSF Proteomic Signature of Idiopathic Normal Pressure Hydrocephalus: A Systematic Review.

  Molecules, Jul 2026

• Idiopathic Intracranial Hypertension Is Characterized by a Distinct Proteomic Profile.

  Ann Neurol, May 2026

• Characterizing CSF inflammatory proteomics in pediatric post-hemorrhagic hydrocephalus and Anti-NMDAR encephalitis.

  J Neuroinflammation, Dec 2025

See which targets of this disease your abstract mentions, and go to the people working on them.